N-[2-oxo-2-(1,2,3,4-tetrahydronaphthalen-1-ylamino)ethyl]-4-phenylpiperazine-1-carboxamide

ID: ALA3718766

Chembl Id: CHEMBL3718766

PubChem CID: 58965355

Max Phase: Preclinical

Molecular Formula: C23H28N4O2

Molecular Weight: 392.50

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CNC(=O)N1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21

Standard InChI:  InChI=1S/C23H28N4O2/c28-22(25-21-12-6-8-18-7-4-5-11-20(18)21)17-24-23(29)27-15-13-26(14-16-27)19-9-2-1-3-10-19/h1-5,7,9-11,21H,6,8,12-17H2,(H,24,29)(H,25,28)

Standard InChI Key:  DVJVPFDKQYEMLG-UHFFFAOYSA-N

Associated Targets(Human)

TAOK1 Tchem Serine/threonine-protein kinase TAO1 (2019 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TAOK3 Tchem Serine/threonine-protein kinase TAO3 (1005 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 392.50Molecular Weight (Monoisotopic): 392.2212AlogP: 2.71#Rotatable Bonds: 4
Polar Surface Area: 64.68Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.78CX Basic pKa: 3.42CX LogP: 2.65CX LogD: 2.65
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.84Np Likeness Score: -1.46

References

1.  (2007)  Tao Kinase Modulators And Method Of Use, 

Source